xi jin

Affiliations: 
Celgene 
Google:
"xi jin"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang Y, Sanders M, Feng W, et al. (2019) Using epidemiological data to identify needs for child-rearing support among Chinese parents: a cross-sectional survey of parents of children aged 6 to 35 months in 15 Chinese cities. Bmc Public Health. 19: 1470
Luo X, Zhou Y, Zheng R, et al. (2019) Association of health-risk behaviors and depressive symptoms and anxiety symptoms: a school-based sample of Chinese adolescents. Journal of Public Health (Oxford, England)
Zhao S, Liu XY, Jin X, et al. (2019) Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer. Theranostics. 9: 4935-4945
Al-Jameel W, Gou X, Jin X, et al. (2019) Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ. Genes & Cancer. 10: 80-96
Li X, Luo X, Zheng R, et al. (2019) The role of depressive symptoms, anxiety symptoms, and school functioning in the association between peer victimization and internet addiction: A moderated mediation model. Journal of Affective Disorders. 256: 125-131
Jin X, Xu XE, Jiang YZ, et al. (2019) The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science Advances. 5: eaat9820
Liu L, Zhao M, Jin X, et al. (2019) Adaptive endoplasmic reticulum stress signalling via IRE1α-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells. Nature Cell Biology
Sun W, Xu X, Jiang Y, et al. (2019) Transcriptome analysis of Luminal Breast Cancer Reveals a Role for LOL in Tumor Progression and Tamoxifen Resistance. International Journal of Cancer
Liu XY, Ma D, Xu XE, et al. (2018) Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer. Theranostics. 8: 6386-6399
Ren YX, Hao S, Jin X, et al. (2018) Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer. Breast (Edinburgh, Scotland). 43: 97-104
See more...